Universe Pharmaceuticals Inc (NASDAQ:UPC) operates within the biotechnology sector, offering pharmaceutical solutions with a ...

Sharps Technology begins shipping smart syringes from Hungary facility, using new automation to meet rising global demand in ...

(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial ...

Bristol Myers Squibb will pay $1.5 billion upfront to BioNTech SE for rights to co-develop and commercialize the German ...

On a positive note, ivonescimab, when used alongside chemotherapy, reduced the risk of disease progression or mortality by 48 ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Septerna (SEPN ... current GLP-1 drugs address. Septerna's stock was up 64% in premarket trading on Wednesday ...

Get stock picks, daily rankings ... according to Benzinga Pro. Photo: Courtesy of Sangamo Therapeutics.

In addition, Krystal’s subsidiary, Jeune Inc., is a biotech working on a skin-optimized gene delivery technology to address aesthetic skin conditions, including aging or photo-damaged skin.

Case in point: Bluebird Bio is a biotech company with three approved gene-editing treatments, but its stock continues to perform terribly. Revenue isn't coming fast enough for investors to change ...